v3.26.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenues $ 1,141,607 $ 1,132,533
Cost of Sales 386,856 137,677
Gross Profit 754,751 994,856
Operating Expenses:    
Sales and Marketing 3,069,104 2,644,095
Research and Development 1,415,032 1,583,250
General and Administrative 4,333,577 4,823,230
Impairment Expense 1,000,000
Total Operating Expenses 9,817,713 9,050,575
Operating Loss (9,062,962) (8,055,720)
Other Income (Expense)    
Loss on Disposal of Assets (149,125)
Gain on Extinguishment of debt 66,076
Unrealized Loss on Change in Derivative Liabilities (320,404) (106,513)
Other Income 111,517 56,399
Interest Income 13,099
Interest Expense (1,065,797) (359,408)
Total Other Income (Expense) (1,410,710) (343,446)
Loss before taxes (10,473,672) (8,399,166)
Income Tax Provision
Net Loss (10,473,672) (8,399,166)
Less: Series B Preferred Stock Dividends (403,603)
Net Loss Available to Common Stockholders $ (10,877,275) $ (8,399,166)
Net Loss Per Share:    
Basic $ (0.38) $ (0.41)
Diluted $ (0.38) $ (0.41)
Weighted Average Common Shares Outstanding:    
Basic 30,154,631 20,491,422
Diluted 30,154,631 20,491,422